Patent intelligence · US
US 9132096
Abuse resistant pharmaceutical compositions
Abuse resistant pharmaceutical compositions
Patent details — US 9132096
- Jurisdiction
- US
- Status
- granted
- Grant date
- Sep 15, 2015
- Expiration
- Sep 10, 2035
- Applicant
- REKHI GURVINDER SINGH [US]
- CPC classes
- A61K 9/ 16 A I, A61K 9/ 50 A I, A61K 31/ 485 A I, A61K 47/ 02 A I
Quick answer
US 9132096 (Abuse resistant pharmaceutical compositions) is held by REKHI GURVINDER SINGH [US]. Status: granted. Granted Sep 15, 2015. Expires Sep 10, 2035 (9 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- REKHI GURVINDER SINGH [US]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 9/ 16 A I, A61K 9/ 50 A I, A61K 31/ 485 A I, A61K 47/ 02 A I, A61K 47/ 10 A I, A61K 47/ 14 A I
More from REKHI GURVINDER SINGH [US]
Related pharmaceutical patents in our USPTO index.
-
AU 2022263543
Pharmaceutical compositions comprising sorbitan esters
granted -
US 2023302008
METHODS OF ADMINISTERING INTRAVENOUS MELOXICAM IN A BOLUS DOSE
granted -
WO 2023156493
FORMES CRISTALLINES DE NALTREXONE
granted -
WO 2023154894
COMPOSITIONS ET PROCÉDÉS D'IMMUNOTHÉRAPIE ANTICANCÉREUSE
granted -
CY 2022006
ΠΡΟΦΑΡΜΑΚΑ ΦΟΥΜΑΡΙΚΩΝ ΑΛΑΤΩΝ ΚΑΙ Η ΧΡΗΣΗ ΤΟΥΣ ΣΤΗΝ ΑΓΩΓΗ ΠΟΙΚΙΛΩΝ ΝΟΣΩΝ
granted -
US 2022354866
IMMEDIATE RELEASE MULTILAYER TABLET
granted -
CA 3172871
COMPOSITIONS DE POLYPEPTIDES DE FUSION D'IL-2 ET LEURS PROCEDES DE FABRICATION ET D'UTILISATION
granted -
CA 3172874
COMPOSITIONS DE POLYPEPTIDES DE FUSION D'IL-2 ET LEURS PROCEDES DE FABRICATION ET D'UTILISATION
granted
Frequently asked questions
What is US patent 9132096?
US 9132096 (Abuse resistant pharmaceutical compositions) is held by REKHI GURVINDER SINGH [US]. Status: granted. Granted Sep 15, 2015. Expires Sep 10, 2035 (9 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 9132096?
REKHI GURVINDER SINGH [US] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does US 9132096 expire?
Our index shows an expiration date of Sep 10, 2035 (9 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.